<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01576003</url>
  </required_header>
  <id_info>
    <org_study_id>2010-2706</org_study_id>
    <nct_id>NCT01576003</nct_id>
  </id_info>
  <brief_title>Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants</brief_title>
  <official_title>Efficacy of Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital Medical Center, Cincinnati</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Emmaus Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Children's Hospital Medical Center, Cincinnati</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to evaluate the effects (good and bad) of
      supplementation with Glutamine to that of a placebo (L-alanine), on your child and their
      Short Bowel Syndrome. Researchers are doing this study to see if the addition of Glutamine to
      oral/tube feeding (nutrition therapy) will work better by preventing bloodstream infections,
      improving growth, and/or changing the make-up of bacteria in your child's intestine.
      Glutamine is approved by the FDA for use in adults with Short Bowel Syndrome. In this study,
      the investigators will be assessing how well Glutamine affects Short Bowel Syndrome in
      children.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a double-blind, randomized placebo-controlled pilot study to investigate the efficacy
      of enteral glutamine (GLN) supplementation in 36 infants, â‰¤ 12 months of age with parenteral
      nutrition (PN)-dependent short bowel syndrome (SBS) due to massive small bowel resection for
      NEC and/or atresia on improving weaning of PN and preventing infections. The investigators
      intend to evaluate the effect of enteral feeding and GLN supplementation on the gut bacteria.
      The investigators will also recruit 12 age-matched controls to evaluate the normal gut
      bacteria.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of bloodstream infections</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assess the efficacy of therapy with enteral GLN on length and weight velocity</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assess the gut lumenal microbiome</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Bloodstream Infections</condition>
  <condition>Short Bowel Syndrome</condition>
  <condition>Development</condition>
  <condition>Nutrition</condition>
  <condition>Biological Markers</condition>
  <arm_group>
    <arm_group_label>Glutamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>L-alanine</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Glutamine</intervention_name>
    <description>0.3 g/kg, taken orally/feeding tube every 12 hours/twice a day for 180 days (6 months)</description>
    <arm_group_label>Glutamine</arm_group_label>
    <other_name>NutreStore</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>L-alanine</intervention_name>
    <description>0.3 g/kg, taken orally/feeding tube every 12 hours/twice a day for 180 day (6 months)</description>
    <arm_group_label>L-alanine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria for Controls:

          -  Less than or equal to 12 months of age

          -  Normal small bowel length without any intestinal resection or primary intestinal
             disease

          -  Not currently on TPN and if ever on TPN this should have been discontinued for at
             least 4 weeks.

        Exclusion Criteria for Controls:

          -  Major congenital or chromosomal anomalies

          -  Inability to tolerate enteral nutrition/regular cow's milk, breast milk or formula

          -  History of liver/intestinal transplantation

        Inclusion Criteria for Glutamine and Placebo Group of SBS Patients:

          -  Less than or equal to 12 months of age

          -  Patients who have undergone small bowel resection due to NEC or intestinal atresia
             with known small bowel length

          -  Patients who have been PN dependent for more than 42 consecutive days and currently on
             TPN at time of enrollment

          -  Patients who have the ability to take partial enteral nutrition or breast milk or
             elemental formula to allow the appropriate dose of glutamine or placebo

          -  Signed informed consent for the use of Glutamine or placebo

        Exclusion Criteria for Glutamine and Placebo Group of SBS Patients:

          -  Major congenital or chromosomal anomalies

          -  Inability to tolerate enteral nutrition that will preclude treatment with enteral
             Glutamine or L-alanine placebo for &gt; 2 weeks

          -  Liver/Intestinal transplantation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Weeks</minimum_age>
    <maximum_age>12 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Conrad R Cole, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital Medical Center, Cincinnati</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>C.S. Mott Children's Hosptial</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 10, 2012</study_first_submitted>
  <study_first_submitted_qc>April 11, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 12, 2012</study_first_posted>
  <last_update_submitted>July 28, 2015</last_update_submitted>
  <last_update_submitted_qc>July 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 29, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Short Bowel Syndrome</keyword>
  <keyword>Necrotizing Entercolitis (NEC)</keyword>
  <keyword>Atresia</keyword>
  <keyword>Parenteral Nutrition</keyword>
  <keyword>Biological Markers</keyword>
  <keyword>Growth</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Short Bowel Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

